Calabresi L - Search Results

1

Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders.

Turri M, Marchi C, Adorni MP, Calabresi L, Zimetti F. Turri M, et al. Among authors: calabresi l. Biochim Biophys Acta Mol Cell Biol Lipids. 2022 May;1867(5):159123. doi: 10.1016/j.bbalip.2022.159123. Epub 2022 Feb 11. Biochim Biophys Acta Mol Cell Biol Lipids. 2022. PMID: 35151900 Review.

2

Apolipoprotein A-II modulates HDL remodeling in plasma.

Calabresi L, Banfi C, Sirtori CR, Franceschini G. Calabresi L, et al. Biochim Biophys Acta. 1992 Mar 4;1124(2):195-8. doi: 10.1016/0005-2760(92)90098-g. Biochim Biophys Acta. 1992. PMID: 1543740

3

Apolipoprotein AIMilano. Partial lecithin:cholesterol acyltransferase deficiency due to low levels of a functional enzyme.

Franceschini G, Baio M, Calabresi L, Sirtori CR, Cheung MC. Franceschini G, et al. Among authors: calabresi l. Biochim Biophys Acta. 1990 Mar 12;1043(1):1-6. doi: 10.1016/0005-2760(90)90102-4. Biochim Biophys Acta. 1990. PMID: 2106917

4

Alterations in the HDL system after rapid plasma cholesterol reduction by LDL-apheresis.

Franceschini G, Apebe P, Calabresi L, Busnach G, Minetti L, Vaccarino V, Sirtori CR. Franceschini G, et al. Among authors: calabresi l. Metabolism. 1988 Aug;37(8):752-7. doi: 10.1016/0026-0495(88)90010-8. Metabolism. 1988. PMID: 3405092

5

Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma.

Murakami T, Michelagnoli S, Longhi R, Gianfranceschi G, Pazzucconi F, Calabresi L, Sirtori CR, Franceschini G. Murakami T, et al. Among authors: calabresi l. Arterioscler Thromb Vasc Biol. 1995 Nov;15(11):1819-28. doi: 10.1161/01.atv.15.11.1819. Arterioscler Thromb Vasc Biol. 1995. PMID: 7583561

6

The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux.

Bernini F, Calabresi L, Bonfadini G, Franceschini G. Bernini F, et al. Among authors: calabresi l. Biochim Biophys Acta. 1996 Jan 5;1299(1):103-9. doi: 10.1016/0005-2760(95)00200-6. Biochim Biophys Acta. 1996. PMID: 8555242

7

Human apolipoprotein A-II inhibits the formation of pre-beta high density lipoproteins.

Calabresi L, Lucchini A, Vecchio G, Sirtori CR, Franceschini G. Calabresi L, et al. Biochim Biophys Acta. 1996 Nov 11;1304(1):32-42. doi: 10.1016/s0005-2760(96)00102-6. Biochim Biophys Acta. 1996. PMID: 8944748

8

Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.

Favari E, Lee M, Calabresi L, Franceschini G, Zimetti F, Bernini F, Kovanen PT. Favari E, et al. Among authors: calabresi l. J Biol Chem. 2004 Mar 12;279(11):9930-6. doi: 10.1074/jbc.M312476200. Epub 2003 Dec 29. J Biol Chem. 2004. PMID: 14701812 Free article.

9

High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli.

Gomaraschi M, Basilico N, Sisto F, Taramelli D, Eligini S, Colli S, Sirtori CR, Franceschini G, Calabresi L. Gomaraschi M, et al. Among authors: calabresi l. Biochim Biophys Acta. 2005 Sep 15;1736(2):136-43. doi: 10.1016/j.bbalip.2005.08.003. Biochim Biophys Acta. 2005. PMID: 16135414

10

Functional LCAT is not required for macrophage cholesterol efflux to human serum.

Calabresi L, Favari E, Moleri E, Adorni MP, Pedrelli M, Costa S, Jessup W, Gelissen IC, Kovanen PT, Bernini F, Franceschini G. Calabresi L, et al. Atherosclerosis. 2009 May;204(1):141-6. doi: 10.1016/j.atherosclerosis.2008.08.038. Epub 2008 Sep 6. Atherosclerosis. 2009. PMID: 18922527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page